Evaluating the Glucantime Concentration for the Glial Cell Model of Antimony-resistant Amastigotes.

Objective: Because the protocols used in the treatment of leishmaniasis can be toxic and have many limitations, such as the development of resistance against such protocols, new treatment options are needed, especially against resistant patients. models may be a good source for evaluating new drug options for patients with antimony-resistant parasites. This study aimed to evaluate the Glucantime concentration for our glial cell amastigote model we had defined in previous work.

Methods: We prepared the astroglial cell culture from brains of 2 to 3 day old neonatal Sprague-Dawley rats under sterile conditions by modifying McCarthy's method. Four plates of cells were infected with antimony-resistant promastigotes. After 24 h of incubation, we added Glucantime to 3 plates with different concentrations. After 72 h, we removed the supernatant and then dried, fixed, and stained the plates with Giemsa to count the amastigotes in the glial cells.

Results: We observed the amastigotes in glial cells in the control flask. Glial cells were ruined in flasks, which include 75 μg/mL and 37.5 μg/mL Glucantime. The number of amastigotes per 100 glial cells was 116 for the flask with 7.5 μg/mL Glucantime concentration, while 487 for the control flask.

Conclusion: We found that while high concentrations of Glucantime were toxic for glial cells, 7.5 μg/mL Glucantime concentration managed to reduce the number of amastigotes in glial cells.